Main content

Rugby League Reference Centre

Therapeutic Use Exemption (TUE) for the use of a prohibited substance

Elite level athletes should first seek advice regarding the legitimate therapeutic use of a prohibited substance or method via their National Sporting Organisation (NSO) medical officer. International level athletes may also need to seek advice from their International Federation medical officer.

All Beta-2 agonists are now allowed except Terbutaline (Bricanyl). If a player is using Terbutaline (Bricanyl) he must apply for a TUE from ASDMAC (Australian Sports Drug Medical Advisory Committee). The use of other Beta-2  no longer require a “declaration of use”.

Asthmatics who use Salbutamol or Salmeterol no longer need to have a TUE and do not have to declare the use. Those who use Terbutaline (Bricanyl will still need a FULL TUE. ) Efomoterol (Foradile, Oxis Turbuhaler or Symbicort) by inhalation is now allowed and no longer requires a TUE.

ASDMAC manages and considers TUE applications for substances that are subject to the standard TUE application process. The status of substances you are taking can be checked by contacting the ASADA Anti-Doping Hotline on 1800 020 506. The Anti-Doping Hotline is a free, anonymous drugs in sport information service. Athletes and their support staff should contact the Anti-Doping Hotline for advice regarding the status of substances. The Anti-Doping Hotline operator will provide each caller with a call number that can be used as a reference for the advice provided.

Once advice has been sought and the need for a standard TUE has been identified athletes should formally apply to ASDMAC by submitting the ASDMAC Standard TUE application form available from the ASDMAC website, with the required supporting documentation as per note two on page 2 of the application form.

ASDMAC will only accept applications on the Standard TUE application form below for consideration. All applications are processed as soon as possible, however urgent requests should be marked as such. A full clinical history, investigations and information as to failed treatment with permitted medications will need to be provided, as per note two of the application form. ASDMAC advises all applicants of the committee’s decision once it has considered the Standard TUE application.

To download the appropriate ASDMAC TUE form please visit